Press Release: Folium Biosciences : One Year After Securing API License for Pharma Grade CBD, Folium Biosciences Reports Broad Global Pharmaceutical Adoption

COLORADO SPRINGS, Colo., Oct. 15, 2020 /PRNewswire/ -- Since securing its Active Pharmaceutical Ingredient (API) license one year ago, Folium Biosciences' CBD Isolate has been widely adopted for pharmaceutical formulations worldwide in countries with stringent cannabinoid regulations -...